What is this study trying to find out about prostate cancer?

This study aims to describe the characteristics and care of prostate cancer patients in Algeria. Researchers want to understand demographic, clinical, diagnostic, and treatment patterns to improve knowledge about prostate cancer management. The study is led by the Société Algérienne de Formation et Recherche en Oncologie.

Who may be eligible for this prostate cancer clinical trial?

Men aged 19 years and older with a confirmed diagnosis of prostate cancer who are followed in certain oncology centers may be eligible. Participants cannot have other types of tumors or be part of other interventional studies. Please review eligibility criteria for more details.

Is there any cost to participate in this prostate cancer clinical trial?

Study-related care, including interviews and data collection, is provided at no cost. Personal travel expenses may vary and are not guaranteed to be covered by the study.

Actively Recruiting

Age: 19Years +

MALE

ID07484971

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Led by Société Algérienne de Formation et Recherche en Oncologie · Updated on 2026-04-17

2000

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying prostate cancer patients in Algeria to describe their demographic, clinical, diagnostic, and treatment characteristics. This observational study focuses on patients with confirmed prostate cancer and aims to analyze how the disease is diagnosed and managed in local oncology centers. Data will be collected through medical records and patient interviews lasting about 30 minutes. The study plans to enroll up to 500 patients and will use a standardized electronic form to gather information on medical history, clinical features, diagnostic tests, and treatment methods. All collected data will be anonymized for research purposes. Participants will undergo a one-time evaluation including interviews and medical record reviews. Researchers will assess socio-demographic details, family cancer history, lifestyle factors like smoking and alcohol use, symptoms, diagnostic procedures, and treatment approaches. The main outcomes include symptom scores and disease status at the initial visit. The study will also monitor time intervals from symptom onset to diagnosis and treatment, and track any adverse events reported by patients.

CONDITIONS

Brief Title

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Who Can Participate

Age: 19Years +

MALE

Eligibility Criteria

You may qualify if you...

Patients aged 19 years and older
Diagnosis of prostate cancer confirmed histologically and/or biologically
Patients followed in the participating oncology departments
Written informed consent obtained

You will not qualify if you...

Histological types other than carcinoma
Secondary tumors
Participation in an interventional study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - At baseline (initial visit)

Participants undergo collection of clinical and diagnostic information related to prostate cancer including medical history, symptoms, and diagnostic examinations.

1 baseline visit (in-person)

Surveillance

Duration - Cross-sectional at baseline with no ongoing follow-up

Participants who are followed in oncology departments have their disease characteristics and treatment strategies observed through medical record review and structured interviews.

No additional visits beyond baseline

Trial Site Locations

Total: 24 locations

CAC Adrar - Oncology Department

Adrar, Algeria, Algeria, 01000

Not Yet Recruiting

CAC Adrar - Radiotherapy Department

Adrar, Algeria, Algeria, 01000

Not Yet Recruiting

CAC BLIDA - Oncology Department